DJIA 16,804.71 -238.19 -1.40%
NASDAQ 4,422.09 -71.31 -1.59%
S&P 500 1,946.16 -26.13 -1.32%
market minute promo


company name or ticker

3 Partnerships Pushing The Pharmaceutical Sector Forward

Dividend Aristocrats: Time to Buy AbbVie Inc Stock?

AbbVie is an innovative pharma company with an attractive yield and a strong outlook for top-line growth going forward. Here's why investors should dig into this top dividend stock.

Incyte Pharmaceutical: Top Idea For 2H14 With 2 Free Call Options Driving M&A Valuation To $93, Gile

Incyte Pharmaceutical: Top Idea For 2H14 With 2 Free Call Options Driving M&A Valuation To $93, Gilead Most Likely Suitor

Biotech Stock Roundup: AbbVie Ties Up with Infinity, Keryx Slips on FDA Approval - Analyst Blog

Infinity Pharmaceuticals (INFI) Soars: Stock Rises 7.1% - Tale of the Tape

AbbVie Is Betting Big On Infinity Pharmaceuticals But Should You?

Will AbbVie's $805 Million Agreement for Duvelisib Pay Off? - Analyst Blog

Thursday's ETF with Unusual Volume: PBD

Benzinga's Top Upgrades

JMP Securities Upgrades Infinity Pharmaceuticals To Market Outperform

See More Articles...